Covid-19: Results from India’s 12 molnupiravir clinical trials remain unpublished

The results of 12 clinical trials conducted in India looking at the efficacy of molnupiravir —an antiviral drug for covid-19—have not been published a year after completion, researchers have said.Researchers from St George’s, Imperial College London, and the University of Liverpool looked at the availability of data from these trials as of July 2022 for a study released as a preprint.1 They found that, while some details of the findings had been revealed through press releases or conference abstracts, none of the results had been published in a journal or preprint service. This equates to missing data for 13 694 trial participants.“Patient level data would help answer many of the unanswered questions around the molnupiravir trials; however, even summary data are largely absent,” the authors wrote.In particular, questions remain over the efficacy of the drug. In October 2021, the MOVe-OUT trial first reported that it halved the risk of hospital…
Read Original Article: Covid-19: Results from India’s 12 molnupiravir clinical trials remain unpublished »